These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 4503393

  • 1. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP, Dougan L, Holt JA, Jackson JM, Matthews ML, Nelson AJ, Stenhouse NS, Woodliff HJ.
    Med J Aust; 1972 Apr 15; 1(16):789-91. PubMed ID: 4503393
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of Vercyte(A-803) on chronic myelogenous leukemia].
    Kinugasa K, Takaku F, Sasa S, Mizoguchi H, Komine M.
    Naika; 1971 Apr 15; 28(1):151-6. PubMed ID: 5284419
    [No Abstract] [Full Text] [Related]

  • 3. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.
    Br Med J; 1968 Jan 27; 1(5586):201-8. PubMed ID: 5235190
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of chronic leukaemia.
    Shaw S.
    Practitioner; 1970 Jun 27; 204(224):773-9. PubMed ID: 5271298
    [No Abstract] [Full Text] [Related]

  • 5. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R, McDonald GA, Baikie AG, Douglas AS.
    Br J Haematol; 1972 Sep 27; 23(3):283-8. PubMed ID: 4507535
    [No Abstract] [Full Text] [Related]

  • 6. Current concepts in the treatment of chronic myelocytic leukemia.
    Sokal JE.
    Annu Rev Med; 1973 Sep 27; 24():281-8. PubMed ID: 4575858
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.
    Hankins DG, Sanders S, MacDonald FM, Drage CW.
    Chest; 1978 Mar 27; 73(3):415-6. PubMed ID: 272980
    [Abstract] [Full Text] [Related]

  • 8. Uracil mustard in the treatment of thrombocythemia.
    Robertson JH.
    Blood; 1970 Mar 27; 35(3):288-97. PubMed ID: 5265825
    [No Abstract] [Full Text] [Related]

  • 9. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J, Outeiriño J, de Villalobos E, Valera M, Alonso M, Calabuig MT, Paniagua G.
    Sangre (Barc); 1981 Mar 27; 26(1):65-71. PubMed ID: 6942520
    [No Abstract] [Full Text] [Related]

  • 10. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID, Wiltshaw E.
    Br J Haematol; 1978 Sep 27; 40(1):59-64. PubMed ID: 280361
    [Abstract] [Full Text] [Related]

  • 11. [COMBINED TREATMENT OF CHRONIC MYELOCYTIC LEUKEMIA].
    SPASSKII OV.
    Sov Med; 1963 Dec 27; 27():9-14. PubMed ID: 14150370
    [No Abstract] [Full Text] [Related]

  • 12. Therapy of chronic granulocytic leukemia.
    Crosby WH.
    Arch Intern Med; 1977 Dec 27; 137(12):1717-8. PubMed ID: 270965
    [No Abstract] [Full Text] [Related]

  • 13. The treatment of chronic granulocytic leukaemia.
    Canellos GP.
    Clin Haematol; 1977 Feb 27; 6(1):113-28. PubMed ID: 334404
    [No Abstract] [Full Text] [Related]

  • 14. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD, Shaw S, Paradinas FJ.
    Postgrad Med J; 1977 May 27; 53(619):267-9. PubMed ID: 267281
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy of chronic myelocytic leukemia.
    Galton DA.
    Semin Hematol; 1969 Oct 27; 6(4):323-43. PubMed ID: 4900650
    [No Abstract] [Full Text] [Related]

  • 16. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A, Smakowska E, Waszkiewicz L, Błaczkowska A, Kin-Dittmann I, Zielińska K, Czajkowska B, Pajsert E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct 27; 111(3):271-5. PubMed ID: 6205949
    [Abstract] [Full Text] [Related]

  • 17. [Cytostatic therapy of chronic myelosis and polycythemia vera with myelobromol (dibrommannitol)].
    Helbig W, Schwenke H, Müldner J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Oct 27; 92(2):182-96. PubMed ID: 4189864
    [No Abstract] [Full Text] [Related]

  • 18. COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA.
    FROMMEYER WB.
    Cancer; 1964 Mar 27; 17():288-96. PubMed ID: 14132176
    [No Abstract] [Full Text] [Related]

  • 19. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M, Lewis D, Walker H.
    Br J Haematol; 1985 Apr 27; 59(4):738-40. PubMed ID: 3857075
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].
    Morales Polanco MR, Butron L, Echegoyen G, Pizzuto Chavez J.
    Sangre (Barc); 1977 Apr 27; 22(2):243-51. PubMed ID: 266289
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.